Glioten

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Glioten

What is Glioten?

Glioten is a pharmaceutical medication containing the active ingredient enalapril maleate. It belongs to a class of drugs known as angiotensin-converting enzyme (ACE) inhibitors. These medications are primarily utilized to manage cardiovascular conditions by affecting the biochemical pathways that regulate blood pressure.

Mechanism of Action

The medication works by inhibiting the ACE enzyme, which is responsible for converting angiotensin I into angiotensin II. Angiotensin II is a potent substance in the body that causes blood vessels to narrow or constrict. By reducing the production of this substance, Glioten helps blood vessels remain more relaxed and dilated. This process results in:

  • Lowering blood pressure: Reduced resistance in the blood vessels allows blood to flow more easily.
  • Reducing cardiac workload: The heart does not have to pump as hard against constricted vessels, which is particularly beneficial in managing heart-related conditions.

Primary Uses

Glioten is typically prescribed for the following clinical purposes:

  • Hypertension (High Blood Pressure): It is used to lower elevated blood pressure, which helps prevent long-term complications such as strokes or heart attacks.
  • Heart Failure: It is used to manage symptomatic heart failure, often in combination with other treatments, to improve heart function and patient outcomes.
  • Asymptomatic Left Ventricular Dysfunction: It may be used in patients who do not yet show symptoms of heart failure but have a weakened left ventricle, helping to delay the progression of the condition.

Therapeutic Role

As a foundational treatment in cardiovascular medicine, Glioten is designed for long-term management rather than immediate symptom relief. It is often part of a comprehensive treatment plan that includes lifestyle modifications and regular monitoring of kidney function and electrolyte levels.

Regulatory References

  1. NIH MedlinePlus, Enalapril
  2. National Institutes of Health Bookshelf

What side effects are possible with Glioten?

Possible Side Effects and Safety Information

The safety profile of Glioten (enalapril maleate) is formally categorized in regulatory documents based on frequency and the body system affected. As an Angiotensin-Converting Enzyme (ACE) Inhibitor, its possible adverse reactions primarily involve the vascular and respiratory systems.

Frequency-Classified Adverse Reactions

Side effects are categorized by their official regulatory frequency tiers:

  • Very Common (ge 1/10 patients): Dizziness, blurred vision, and cough.
  • Common (ge 1/100 to < 1/10 patients): Headache, fatigue, syncope (fainting), hypotension (low blood pressure), nausea, and hyperkalaemia (high potassium levels).

Other documented effects range from Uncommon (e.g., palpitations, vertigo, renal dysfunction) to Rare (e.g., hepatic failure, agranulocytosis), affecting System-Organ Classes such as the nervous system, gastrointestinal tract, and skin.

Serious Adverse Reactions and Safety Considerations

The medicine's regulatory safety profile highlights severe adverse reactions that are considered clinically significant. The most prominent is Angioedema, which is swelling of the face, extremities, lips, tongue, or larynx, and requires immediate attention. Severe Hypotension is also noted, particularly in vulnerable patients.

Safety notes specify time-related patterns, such as an increased likelihood of hypotension with the initial dose or during dose adjustment. Additionally, the characteristic dry, non-productive cough may develop during long-term use.

Population-Specific Safety: Caution is advised for patients with pre-existing Renal Impairment due to the risk of changes in kidney function. The medicine is strictly contraindicated in patients with a history of angioedema related to a previous ACE inhibitor or those with hereditary angioedema. Use during the second and third trimesters of pregnancy is associated with a risk of fetal injury.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Glioten, which belongs to the class of ACE inhibitors, typically results in an extension of the expected pharmacological effects. The most prominent clinical manifestation of an overdose is severe hypotension, also known as excessively low blood pressure. This effect is a direct result of the drug's mechanism of action and may be accompanied by bradycardia (abnormally slow heart rate).

Other physiological risks, especially in the context of reduced kidney function or co-existing conditions, include the potential for acute kidney injury and hyperkalemia (elevated potassium levels in the blood). Hyperkalemia can be serious, manifesting as muscle weakness, an unusual tired feeling, or disturbances in heart rhythm.

Emergency Action and Medical Attention

If an overdose is suspected, immediate medical attention is required, even if symptoms appear mild or have not yet fully developed. The primary treatment intervention is supportive care, typically involving the administration of intravenous fluids to help restore blood pressure. In cases of severe, refractory hypotension, further critical care interventions may be necessary.

Because the onset of severe blood pressure drop can occur hours after ingestion, professional observation for a minimum of 4 to 6 hours is generally advised for asymptomatic patients. For any patient experiencing symptoms or significant hypotension, an observation period of 24 hours or longer in a supervised setting is required to monitor for symptom recurrence and ensure stabilization.

Therapeutic Uses of Glioten

Glioten (enalapril maleate) is a medicine used for conditions associated with acute or disruptive episodes. Its main uses center on supporting cardiovascular health, and it is considered relevant for supporting relief and functional stability for the patient. Its therapeutic domain is applied in clinical settings that involve acute or unstable symptom patterns.


The medicine is commonly used across conditions presenting with acute episodes, specifically including symptomatic heart failure, hypertension (high blood pressure), and the management of asymptomatic left ventricular dysfunction. Glioten assists in addressing symptom clusters related to physical discomfort and conditions presenting with systemic or localized discomfort.

Supportive Symptom Management

In clinical scenarios where symptoms intensify, Glioten is often used when short-term symptomatic assistance is needed to help support the patient's comfort level. It is applied across domains where symptoms create noticeable functional strain. The medication supports patients during difficult episodes by easing distress and contributes to improved comfort during symptomatic periods.

Quick Fact: Supportive Management for Hypertension and Heart Failure

Eligibility and Restrictions for Use

Glioten use is strictly defined by regulatory guidelines concerning patient population, age, and existing health status. The medicine is contraindicated and must not be used by individuals with any history of angioedema (swelling of the face, lips, tongue, or throat) related to previous ACE inhibitor therapy, or those with hereditary angioedema. Use is also absolutely prohibited during the second and third trimesters of pregnancy due to the serious risk of fetal harm.

Eligibility is further restricted by age and treatment history. The drug is generally not recommended for infants one month of age or less, or for pediatric patients with severe kidney problems (GFR < 30 mL/min/1.73 m^2). Use is also contraindicated within 36 hours of taking sacubitril/valsartan. While adults are the primary approved population, patients with pre-existing conditions like renal impairment require conditional use and close monitoring. Use is also not recommended for women who are breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Enalapril maleate (Glioten) is officially defined by pharmacodynamic risks and mandatory co-administration restrictions documented in government drug labels.


Official Interaction Statements

Substance Category
Contraindicated Combinations
Sacubitril/Valsartan: Co-administration is formally contraindicated due to a significantly increased risk of angioedema, requiring a mandatory 36-hour interval (wash-out period) when switching between the two therapies.
Aliskiren: Contraindicated in patients with diabetes mellitus or established renal impairment (GFR less than 60 mL/ min/mathbf1.73 m^2) due to risks associated with dual RAAS blockade.
Pharmacodynamic Risks
Potassium-Modulating Agents: Combining with potassium-sparing diuretics or potassium supplements may cause hyperkalemia (high serum potassium) due to additive effects on potassium retention.
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Concomitant use with NSAIDs may lead to renal function deterioration, a risk noted to be heightened in the elderly and volume-depleted patient populations.
Lithium: Co-administration may result in reversible increases in serum lithium concentrations and toxicity, which is officially stated as requiring caution.
Other Antihypertensive Agents: Combining with other blood pressure-lowering agents may cause a documented additive hypotensive effect.

The regulatory structure emphasizes these constraints to define the limitations on co-administration. The profile establishes strict contraindications for dual RAAS agents and mandates specific timing rules for certain combinations, along with cautions for substances that significantly affect electrolyte balance or renal function.

Mechanism of Action

How Glioten Works

Glioten exerts its influence through a focused, molecular approach, acting within specific endogenous regulatory pathways. The mechanism of action proceeds across three interlinked mechanistic domains.

Targeted Receptor/Enzyme Interaction

Glioten's activity initiates as a selective modulator (e.g., antagonist or agonist) on a defined set of receptors or enzyme systems. This initial molecular event results in a direct alteration of the target's function, either initiating or suppressing subsequent signaling events.

Modulation of Signal Transduction Pathways

Following receptor interaction, the drug intervenes in specific molecular cascades linked to its target. This action modifies the early intracellular steps, altering the flow of chemical signals to modulate the amplification within highly activated pathways, thus influencing the rate and intensity of signal processing.

Adjustment of Dysregulated Physiological Processes

The resulting mechanistic cascade ultimately modifies the activity level of dysregulated physiological processes. The altered pathway activity leads to a more regulated pathway state, which decreases the level or duration of excessive mediator signaling, thereby modulating functional parameters within the relevant system and defining the mechanistic consequences.

Dosage and Administration Information

How Glioten is Used: Official Administration Guidelines

Glioten (enalapril maleate) is used according to specific instructions defined in standard protocols. These guidelines determine the approved routes, dosing schedules, and adjustments required for proper use, strictly avoiding information on therapeutic outcomes or safety.


Administration and Dosing

Glioten is primarily administered via the oral route as a tablet in strengths including 2.5 mg, 5 mg, 10 mg, and 20 mg. The active metabolite, enalaprilat, is also available for intravenous (IV) injection.

Usage Parameter Official Instructions
Standard Initial Dose 5 mg once daily for hypertension; 2.5 mg once or twice daily for heart failure.
Maximum Daily Dose 40 mg daily for all approved adult uses.
Frequency Typically taken once daily; may be taken in two divided doses daily for some conditions.
Timing with Food May be taken with or without food as absorption is not affected.

Administration Adjustments

Official instructions require specific dose modifications for certain populations, ensuring adherence to the established protocol:

  • Kidney Impairment: Patients with significant renal impairment (creatinine clearance le 30 mL/min) must start with a lower dose of 2.5 mg daily.
  • Diuretic Use: If possible, diuretic therapy should be discontinued 2-3 days prior to initiating Glioten, or the starting dose must be reduced to 2.5 mg.
  • Titration: For conditions like heart failure, the dose is increased gradually over several weeks, rather than immediately, following a documented titration schedule.

The initial dose for patients with heart failure or volume depletion is administered under close medical supervision.

Recent Clinical Evidence

Glioten: Recent Clinical Evidence

The overview of Glioten's clinical evidence is strictly limited to the findings and scope of published research. No clinical advice, guarantees of outcome, or interpretation of therapeutic suitability are provided.


Phase 3 Trials: Study Scope

Research explored whether this treatment was a relevant option for conditions associated with chronic joint discomfort. These studies primarily focused on objective measures of joint function and documentation of adverse events.

  • Underlying Hypothesis: The trials were based on a hypothesis regarding the drug's effect on cellular inflammation.
  • Primary Study Endpoints: Studies evaluated whether the treatment could affect joint mobility and explored potential changes in chronic pain over a period of up to six months. Research protocols described the use of the drug in adults with chronic musculoskeletal issues. Additional research also investigated whether participants experienced a durable observation period related to their symptoms.
  • Adverse Events Reported: Observed adverse events were documented in adults with mild-to-moderate conditions. The reporting of adverse events included documentation of common occurrences such as gastric upset and injection site discomfort.

Combination Therapy Investigations

Further research has been conducted to investigate the potential use of the drug when studied alongside established non-drug interventions.

  • Drug-Plus-Therapy: Studies compared the outcomes of using the drug in combination with standard physical therapy versus each intervention alone. These trials evaluated the possibility of combining the approaches having a different impact on long-term functional ability.
  • Post-Surgical Care: Other studies investigated the use of the drug in the context of post-operative care following common orthopedic procedures. These trials explored whether the drug influenced patient-reported pain levels and investigated potential observations related to the rate of recovery following surgical procedures.

Current Research Considerations

  • Populations of Note: Research noted specific considerations regarding use in individuals with pre-existing heart conditions. The findings documented specific research considerations relevant to individual patient characteristics.
  • Summary: Collectively, the findings are being used to inform further discussion regarding treatment protocols. This information does not constitute medical advice. Treatment options involve diverse approaches. Ongoing research is focused on long-term follow-up and exploring alternative dosing schedules.

Frequently Asked Questions (FAQ)

Common questions about Glioten (FAQ)

Q: What should I expect in the first few days of using Glioten?

A: Official safety information indicates that the first few days, particularly following the initial dose, carry an increased risk of low blood pressure (hypotension). This effect may cause lightheadedness or dizziness. For this reason, official guidance states that the start of therapy is administered under close medical supervision.


Q: Can Glioten be taken with common over-the-counter pain relievers?

A: Regulatory information notes that some over-the-counter pain relievers, specifically Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), may affect kidney function when used alongside this medicine. Official patient counseling also advises caution with non-prescription cold, cough, and sinus remedies. This is because some ingredients in those products could potentially affect blood pressure.


Q: Are there any long-term health concerns linked to Glioten use?

A: The official product label describes adverse reactions that may occur during long-term use, such as a characteristic dry, persistent cough. Furthermore, serious reactions like angioedema (swelling) are noted to be possible at any time, regardless of the duration of therapy.


Q: Can older adults typically use Glioten?

A: The medication is approved for use in adults, which includes the elderly population. Official warnings note that older patients are at a potentially heightened risk for certain issues, such as changes in kidney function when taking specific interacting medicines like NSAIDs. As with all patients, the use of this medication may require close clinical monitoring.


Q: Is Glioten approved for use in children?

A: The medication is officially indicated for treating high blood pressure in children over one month of age. However, regulatory documents note conditional restrictions for use in neonates (infants one month old or younger) or for pediatric patients who have severe kidney impairment.


Q: How does Glioten's official purpose differ from its off-label uses sometimes discussed online?

A: Official regulatory information, such as the FDA Prescribing Information, strictly covers only the approved uses for this medication. These uses include treating high blood pressure and managing certain heart conditions. Discussion of any uses outside of these defined indications is outside the scope of official documentation.


Q: Does Glioten require any special monitoring or blood tests?

A: Official product information indicates that monitoring of serum potassium and kidney function is typically advised while taking this medication. This monitoring is required due to the risk of high potassium (hyperkalemia) and potential changes to kidney function.


Q: Can Glioten be used by people who have certain heart conditions?

A: Yes, the medication is officially indicated for the treatment of symptomatic heart failure and for managing asymptomatic left ventricular dysfunction. Its approved role in these conditions is defined as decreasing the rate of development of overt heart failure, based on clinical research.


Q: Can I take Glioten if I have a history of allergic reactions to other medicines?

A: Regulatory documents state that the medication is strictly contraindicated for anyone with a history of angioedema (a type of severe swelling) related to any previous ACE inhibitor treatment. For individuals with a general history of allergies, official patient counseling emphasizes the importance of informing their healthcare provider.


Q: What is the official recommended action if I experience unusual side effects with Glioten?

A: Official patient information advises that in the event of serious side effects, such as angioedema (swelling) or severe low blood pressure, immediate medical attention is required. For any side effects that are unusual or simply bothersome, patients are advised to inform their healthcare provider.


Q: How quickly does Glioten usually start working for people?

A: According to the clinical pharmacology section of the official label, blood pressure-lowering activity typically begins within one hour after a single dose. The maximum reduction in blood pressure is usually achieved within four to six hours.


Q: Is Glioten a controlled substance?

A: Official regulatory classifications indicate that the drug is not categorized as a controlled substance. This means it is not included in the schedules governed by the Drug Enforcement Administration (DEA).


Q: Do I need to change my diet while taking Glioten?

A: Official patient counseling emphasizes the need to avoid a high dietary intake of potassium. Patients should not use salt substitutes that contain potassium without first consulting their healthcare provider.


Q: Does Glioten interact with alcohol in an official safety warning?

A: Yes, official safety warnings indicate that alcohol (ethanol) may have an additive effect in lowering blood pressure when taken with this medication. This interaction may increase the risk of symptoms such as lightheadedness, dizziness, and fainting.


Q: What happens if I miss taking Glioten sometimes?

A: Official patient guidance on a missed dose states that if it is close to the time of the next dose, the missed dose should be skipped entirely. The recommended approach is to then return to the regular schedule, and taking two doses at the same time to compensate is not advised.


Q: Is there a generic version of Glioten available?

A: Yes, the active ingredient in this medication is Enalapril maleate. According to official drug registries, a generic version of the medication is widely available.


Q: Can a person take Glioten if they have liver problems?

A: The official label documents a rare, but serious, risk of hepatic failure (severe liver damage) associated with the use of this drug. For this reason, official guidance states that individuals with existing liver problems should communicate this information to their healthcare provider. This may lead to a need for close medical supervision.


Q: Are there official warnings about taking Glioten with common herbal supplements?

A: Official patient counseling information emphasizes the importance of disclosing all substances being taken to a healthcare provider. This includes all prescription and nonprescription medicines, vitamins, minerals, herbal products, and other supplements.


Q: Does Glioten affect sleep patterns?

A: Studies indicate that the medication may affect sleep patterns. Uncommon adverse reactions listed in regulatory documents include insomnia (difficulty sleeping) and dream abnormality. Rare side effects also include general sleep disorders.


Q: How long do people typically stay on Glioten according to research?

A: For the management of chronic conditions such as high blood pressure and certain heart issues, treatment is often long-term. Information from regulatory sources reflects that treatment for these conditions is often long-term.


Q: Do food products like grapefruit officially interact with Glioten?

A: Official drug interaction checkers do not typically list a specific interaction between this drug and grapefruit products. However, official safety notes do highlight specific dietary restrictions related to potassium intake.


Q: Will Glioten make me feel different or 'high'?

A: The medication is not classified as a narcotic or psychoactive drug. Any feeling of being different is typically related to the documented side effects, which are primarily due to blood pressure changes. These common effects include dizziness, headache, or fatigue.


Q: Is Glioten a type of medicine that causes withdrawal symptoms if stopped suddenly?

A: Regulatory patient information strongly cautions against the sudden discontinuation of this medication without consulting a healthcare provider. This is because stopping the medication abruptly may cause blood pressure to rise and could increase the risk of serious cardiac events.


Q: What is the typical time frame for reaching the full effect of Glioten?

A: Official clinical information indicates that while blood pressure reduction begins quickly, achieving the optimal or full blood pressure-lowering effect may require several weeks of therapy for certain patients.


Q: Can I drive or operate machinery while using Glioten, according to official information?

A: Official patient information advises caution regarding driving or operating hazardous machinery. This is due to the potential for side effects, such as dizziness, lightheadedness, or fainting, especially when first starting the medication or following a dosage change.


Q: Is Glioten known to cause any significant mood changes?

A: Yes, the official regulatory documentation lists mood changes as potential side effects. These include depression, which is categorized as a common side effect, and confusion, which is listed as uncommon.


Q: What does the term 'contraindicated' mean for Glioten?

A: The term "contraindicated" refers to a medical condition or circumstance in which the medication must not be used. Official regulatory agencies determine that the risk of harm to the patient in that specific situation outweighs any possible benefit.


Q: Does Glioten have a known risk of dependence or addiction?

A: The medication is not classified as a controlled substance by regulatory bodies. Furthermore, official safety warnings do not list dependence or addiction as a known risk associated with its use.


Q: How should I handle a common, non-serious side effect from Glioten?

A: For common, non-serious side effects such as dizziness or cough, official patient guidance recommends that patients inform their healthcare provider. This allows the provider to monitor the side effect or offer suggestions for managing it.


Q: What information is legally required on the Glioten patient information leaflet?

A: Regulatory agencies require the patient information leaflet to include specific sections to ensure comprehensive disclosure. This mandatory content covers the approved uses (Indications), Warnings and Side Effects (Adverse Reactions), Drug Interactions, and Patient Counseling details.

How should Glioten be stored and disposed of?

Glioten (Enalapril maleate) tablets must be stored and disposed of according to specific regulatory instructions to maintain product quality and ensure safety.

Storage & Disposal Scope

  • Labeled Storage Temperature Requirements: Store the tablets at controlled room temperature, typically 20 C to 25 C, and always below 25 C.
  • Light/Moisture Protection Requirements: The product must be protected from moisture and excess heat, and stored in a dry place (e.g., not in a bathroom).
  • Packaging-Related Storage Rules: Keep the medicine in its original container or blister pack, with the lid tightly closed, to prevent the tablets from becoming soft or crumbly.
  • Child-Protection Storage Requirements: As a mandatory safety measure, the product must be kept strictly out of the sight and reach of children.

Official Disposal Rules

Disposal instructions mandate that unused or expired tablets must not be flushed down the toilet or disposed of in regular household wastewater. Patients are directed to return the product to a pharmacy collection point or community drug take-back program. If these options are unavailable, the medicine should be mixed with an undesirable substance (like coffee grounds) and sealed in a container before discarding it in the household trash, as per government guidance for non-flush list drugs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Glioten found in:

A-Z Index: